Capital

CapitalBio Corporation is a leading Chinese life science company that specializes in the development and commercialization of biochip-based technologies and products. The company provides a comprehensive range of solutions including microarrays, microfluidic chips, and high-throughput sequencing services for clinical diagnostics, food safety, and pharmaceutical research. CapitalBio is particularly recognized for its innovative diagnostic kits for hereditary deafness and respiratory pathogens, which are widely used in clinical settings across China. By integrating engineering with biology, the company aims to provide advanced tools for personalized medicine and health management.